Compass Therapeutics CMPX
NASDAQ CMPX
$0.83 -0.01 (-0.68%)
As of: Oct 21, 2026 · 9:43 AM EDT

Compass Therapeutics (CMPX) Revenue (2024)

Updated

Compass Therapeutics' Revenue came in at $850,000 for FY2024.

Analysis

Compass Therapeutics (CMPX) Revenue (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,140.41 Bn 1,108.99 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 618.57 Bn 537.10 Bn 17.26 Bn 25.31 Bn
3 AbbVie 509.95 Bn 483.06 Bn 12.70 Bn 16.99 Bn
4 Merck 366.63 Bn 321.01 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.47 Bn 262.46 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 263.21 Bn 236.89 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.71 Bn 192.11 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 193.05 Bn 167.25 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn 15.03 Bn
10 Compass Therapeutics 155.59 Mn -650.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 850,000.00
API Access

Compass Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CMPX&period=max&api_key=YOUR_API_KEY